Pre-Annual General Meeting Information • Oct 28, 2024
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
1
If you are in any doubt about what action to take, you should consult your stockbroker, solicitor, accountant or other appropriate independent professional adviser authorised under the Financial Services and Markets Act 2000. If you have sold or otherwise transferred all of your shares in J D Wetherspoon plc (the 'Company'), please forward this document and the accompanying proxy form to the person through whom the sale or transfer was effected, for transmission to the purchaser or transferee.
Dear Shareholder
I am pleased to invite you to our 2024 Annual General Meeting (the 'Meeting').
The formal notice of Meeting and your proxy form are enclosed.
If you would like to vote on the resolutions, but cannot attend the Meeting, please fill in the proxy form and return it to our registrars at the address detailed in the notes to the notice of Meeting as soon as possible, but in any case by no later than 10am on 19th November 2024. The completion and return of a proxy, or the appointment of a proxy, will not prevent you from attending and voting at the Meeting, or any adjournment of it, in person should you wish to do so. Irrespective of whether or not you propose to attend the Meeting, we would encourage you to appoint the Chair of the Meeting as your proxy. This will ensure that your vote will be counted if ultimately you are (or any proxy you might otherwise appoint is) not able to attend on the day for any reason.
If you plan to attend the Meeting, we also invite you to submit any questions you may want the Company to answer at the Meeting to the address below, for the attention of the Company Secretary, or via e-mail to [email protected] before 10am on 19th November 2024. In addition, questions will be invited from the floor of the Meeting itself. It is hoped that advance notice of some of the questions will enable the Company to select important issues to debate which might otherwise be missed. It might also encourage institutional investors to attend.
If you are intending to attend the meeting could you please indicate in the space provided on the proxy form, or by clicking the relevant box if voting electronically.
The directors consider that all resolutions to be put to the Meeting are in the best interests of the Company and its shareholders as a whole. Each of the directors will be voting in favour of each of the resolutions in respect of their own holdings of shares (save in respect of resolutions in which they are interested) and unanimously recommend that you do so as well.
Yours sincerely
Tim Martin Chairman
Registered office: Wetherspoon House Reeds Crescent Watford WD24 4QL
Registered number: 1709784
Notice is hereby given that the 2024 Annual General Meeting of J D Wetherspoon plc will be held at etc. venues, 50-52 Chancery Lane, London , WC2A 1HL at 10am on 21st November 2024 to consider and, if thought fit, pass the following resolutions.
All resolutions will be proposed as ordinary resolutions, except for resolutions 15, 16, 17 and 18 which will be proposed as special resolutions.
The explanatory notes on pages 5 to 7 give further information on each of the resolutions that are to be proposed at the Meeting.
To consider and, if thought fit, pass the following resolutions as ordinary resolutions:
To consider and, if thought fit, pass the following resolutions, in the case of resolution 14 as an ordinary resolution and in the case of resolutions 15, 16, 17 and 18 as special resolutions:
expiring (unless previously revoked, varied or renewed by the Company) on the date which is 15 months from the date of the passing of this resolution or, if sooner, the end of the next annual general meeting of the Company, provided that the Company may, before such expiry, make an offer or agreement which would or might require Relevant Securities to be allotted after this authority expires, and the directors may allot Relevant Securities in pursuance of such offer or agreement, as if this authority had not expired.
This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Act as if, in the first paragraph of this resolution, the words 'pursuant to the authority conferred by resolution 14' were omitted.
This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of section
560(3) of the Act as if, in the first paragraph of this resolution, the words 'pursuant to the authority conferred by resolution 14' were omitted.
This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Act as if, in the first paragraph of this resolution, the words 'pursuant to the authority conferred by resolution 14' were omitted.
By order of the board
Company Secretary
Wetherspoon House Reeds Crescent Watford WD24 4QL
nominated under section 146 of the Companies Act 2006 (the 'Act') to enjoy information rights (a 'Nominated Person') may, under an agreement between him or her and the member by whom he or she was nominated, have a right to be appointed (or to have someone else appointed) as a proxy for the Meeting. If a Nominated Person has no such proxyappointment right or does not wish to exercise it, he or she may, under any such agreement, have a right to give instructions to the member as to the exercise of voting rights.
www.jdwetherspoon.co.uk/investors-home
For each resolution that is proposed as an ordinary resolution, more than half of the votes cast in respect of the relevant resolution must be in favour of the resolution for it to be passed. For each of the resolutions that are being proposed as a special resolution, at least three-quarters of the votes cast in respect of the relevant resolution must be in favour of the resolution for it to be passed. Voting on all of the proposed resolutions at the Meeting will be conducted on a poll rather than on a show of hands.
The directors recommend that the Company adopt the reports of the directors and the auditors and the audited accounts of the Company for the year ended 28th July 2024.
Resolution 2, which will be proposed as an ordinary resolution, asks shareholders to approve the directors' remuneration report for the year ended 28th July 2024 in the form set out on pages 72 to 80 of the annual report.
In accordance with the remuneration reporting rules, the vote on the report is an advisory vote and so the directors' entitlement to receive remuneration is not conditional on it.
The directors recommend a final dividend of 12.0 pence per share. Subject to approval of the proposed dividend by shareholders, the dividend will be paid on 28th November 2024 to shareholders on the register at close of business on 25th October 2024.
In accordance with the UK Corporate Governance Code, all of the directors of the Company will stand for re-election to the board. The chairman confirms that each director's performance continues to be effective and demonstrates commitment to his or her respective roles, including time commitments for board and committee meetings. The chairman also confirms that the contribution of each director is, and continues to be, important to the Company's long-term sustainable success. Further details, including biographical details, are set out on pages 68 and 81 to 86 of the annual report.
The auditors of the Company must be appointed at each general meeting at which accounts are laid to hold office until the conclusion of the next such meeting. The Company proposes Grant Thornton UK LLP be re-appointed as the Company's auditors for the next financial year and that the Audit Committee of the board authorise its remuneration.
The Companies Act 2006 (the 'Act') prevents directors of a public company from allotting shares, other than pursuant to an employee share scheme, without the authority of shareholders in a general meeting.
In certain circumstances, this could be unduly restrictive. The general authority previously given to the directors to allot 'relevant securities' will expire at the end of the Meeting.
Accordingly, Resolution 14, which will be proposed as an ordinary resolution, authorises the directors (pursuant to section 551 of the Act) to allot ordinary shares:
(A) up to an aggregate nominal amount of £824,147, representing approximately one-third of the nominal value of the ordinary shares in issue as at 16th October 2024 (being the last practicable date prior to the publication of this document); and
(B) up to a further aggregate nominal amount of £824,147, representing approximately an additional one-third of the nominal value of the ordinary shares in issue as at 16th October 2024 (being the last practicable date prior to the publication of this document), provided that they are offered by way of an offer in favour of ordinary shareholders in proportion (as nearly as practicable) to their existing holdings of ordinary shares.
The Company does not currently hold any ordinary shares in treasury.
The authority sought by this resolution (unless previously varied, revoked or renewed) will expire on the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
In accordance with the Investment Association's share capital management guidelines, the limit on the directors' authority to allot shares under section 551 of the Act may be increased from one-third to two-thirds of the Company's issued share capital, provided that the amount of any authority above one-third must be applied to fully pre-emptive offers and should be valid for the period until the conclusion of the next annual general meeting only.
The directors will exercise such authority to allot shares only when satisfied that it is in the interests of the Company to do so. They have no present intention of exercising the authority.
The provisions of section 561 of the Companies Act 2006 (the 'Act') (which confer on shareholders rights of pre-emption in respect of the allotment of 'equity securities' which are, or are to be, paid up in cash, other than by way of allotment to employees under an employee share scheme) apply to the unissued ordinary shares of the Company to the extent that they are not disapplied, pursuant to sections 570 and 573 of the Act.
The current disapplication of these statutory pre-emption rights will expire at the end of the Meeting. Accordingly, Resolution 15, which will be proposed as a special resolution, permits the directors to allot shares without the application of these statutory pre-emption rights: first, in relation to offers of equity securities by way of rights issue, open offer or similar arrangements; and second, in relation to the allotment of equity securities for cash, up to a maximum aggregate nominal amount of £247,244.39 (representing approximately 10% of the nominal value of the ordinary shares of the Company in issue as at 16th October 2024 (being the last practicable date prior to the publication of this document)).
The authority (unless previously varied, revoked or renewed) will expire on the earlier of 15 months from the date of
passing the resolution and the conclusion of the next annual general meeting of the Company.
The directors are following the updated Statement of Principles issued by the Pre-Emption Group on 4 November 2022 (the "Pre-Emption Principles").
Although the directors embrace the flexibility conferred by Resolutions 15 and 16 to issue shares without the application of pre-emption rights, the directors also recognise that existing shareholders may be keen to participate in a non pre-emptive "follow-on" offer carried out under these authorities. The directors are therefore supportive of the ability to make a "follow-on" offer as reflected in the Pre-Emption Principles, and which has been reflected in each of these Resolutions.
The directors confirm that they intend to follow the shareholder protections and approach to follow-on offers contained in Part 2B of the Pre-Emption Principles.
Following the adoption by the Pre-Emption Group of the Pre-Emption Principles, the Company proposes to seek an authority from shareholders for the disapplication of pre-emption rights for an additional 10% of the issued share capital of the Company for the purpose of a specified capital investment.
Resolution 16, which will be proposed as a special resolution, permits the directors to allot shares without the application of the statutory pre-emption rights, in addition to any authority granted under Resolution 15, up to a maximum aggregate nominal amount of £247,244.39 (representing approximately 10% of the nominal value of the ordinary shares of the Company in issue as at 16th October 2024 (being the last practicable date prior to the publication of this document)) to be used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the directors determine to be an acquisition or other capital investment of a kind contemplated by the Pre-Emption Principles.
The authority (unless previously varied, revoked or renewed) will expire on the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
As referenced above, this Resolution 16 includes the ability of the Company to make a follow-on offer of the kind contemplated by the Pre-Emption Principles.
In common with many other listed companies, the Company proposes, once again, to seek an authority from shareholders to permit it to purchase its own shares. Accordingly, Resolution 17 will be proposed as a special resolution to authorise the Company to make market purchases of up to 18,543,329 shares, just under 15% of the Company's
current issued ordinary share capital, at prices not less than the nominal value of an ordinary share and not exceeding 105% of the average of the middle-market quotations for an ordinary share for the five business days before each purchase (in each case, exclusive of expenses). The authority will last until the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
The directors envisage that purchases would be made only after considering the effects on earnings per share and the benefits for shareholders generally.
If Resolution 17 is passed, it is the Company's current intention to cancel all of the shares it may purchase pursuant to the authority granted to it. However, in order to respond properly to the Company's capital requirements and the prevailing market conditions, the board will need to assess at the time of any and each actual purchase whether to hold the shares in treasury or to cancel them, provided it is permitted to do so.
The notice period required for general meetings of the Company is 21 clear days, unless shareholders approve a shorter notice period, which cannot, however, be fewer than 14 clear days. Resolution 18 seeks such approval. The approval will be effective until the Company's next annual general meeting, when it is intended that a similar resolution will be proposed.
In addition, in order to be able to call a general meeting on under 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders at that meeting.
The shorter notice period would not be used as a matter of routine for such meetings, but only where the flexibility is merited by the business of the meeting and is thought to be to the advantage of shareholders as a whole.
Annual general meetings will continue to be held on at least 21 clear days' notice.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.